The anti-cocaine vaccine, developed by researchers at the Federal University of Minas Gerais, Brazil, aims to produce antibodies that bind to cocaine when it is taken. This would make it harder for the substance to pass through the bloodstream to the brain. The vaccine would try to inhibit the brain reactions that trigger the craving.
Latest News
17:45
Tourists scammed by a group of Romanians in London
17:43
Russian authorities remain silent about the funeral of researcher Daria Shipilova, who died under suspicious circumstances
17:40
Czech intelligence chief warns: Russia could intensify attacks on NATO states
17:33
Patriarch Daniel sent Pope Leo XIV a message of support ahead of his surgical procedure
17:28
Investment of 53.8 million euros in the Port of Constanța
See more news